Pfizer’s Covid-19 Pill Failed Study Testing Its Preventive Use – The Wall Street Journal
Pfizer’s Covid-19 Pill Failed Study Testing Its Preventive Use The Wall Street JournalView Full Coverage on Google News
Paxlovid’s key advantage over other Covid-19 treatments has been that it can be taken at home to avoid hospitalization.
Photo: Fabian Sommer/Zuma Press
